Last updated: 15:46
No Notes Added Yet
Sacheerome Ltd. is a company in the fragrances and flavours business: it designs and manufactures fragrances (for personal care, home‑care, fabric care, fine fragrance, etc.) and flavouring solutions (for beverages, bakery, dairy, confectionery, seasonings, oral‑care, and other food/beverage segments). The firm was founded in 1992; while initially focused on fragrances, it expanded into flavours around 2014, and today operates with a dedicated R&D & application centre alongside manufacturing capability. In its financial year 2025, Sacheero...Read More
Sacheerome Ltd. is a company in the fragrances and flavours business: it designs and manufactures fragrances (for personal care, home‑care, fabric care, fine fragrance, etc.) and flavouring solutions (for beverages, bakery, dairy, confectionery, seasonings, oral‑care, and other food/beverage segments). The firm was founded in 1992; while initially focused on fragrances, it expanded into flavours around 2014, and today operates with a dedicated R&D & application centre alongside manufacturing capability. In its financial year 2025, Sacheerome delivered strong growth: revenue rose significantly year‑on‑year, while net profit increased substantially — reflecting healthy demand, improved operational efficiency, and good margin profile. Key financial metrics (returns on equity and capital employed) are reported as solid, and the company maintains a low debt-to-equity ratio, indicating financial prudence. In mid‑2025, Sacheerome launched an Initial Public Offering on the SME platform, and the listing was met with strong investor interest — reflecting market confidence in its business model and growth prospects. The company plans to expand production capacity via a new manufacturing facility, strengthen R&D and scale up operations to capture growing demand in FMCG, food & beverage and personal‑care sectors. Overall, Sacheerome is positioned as a growing specialist supplier of fragrances and flavours — with diversified product applications, improving financials, and a clear growth / expansion roadmap, though as with any niche manufacturing business it remains subject to demand cycles, raw-material price volatility and execution risks. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹744 Cr.
Stock P/E 46.5
P/B 6
Current Price ₹332.5
Book Value ₹ 55.2
Face Value 10
52W High ₹430.7
Dividend Yield 0%
52W Low ₹ 140.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 27 | 34 | 42 | 51 | 54 | 52 | 59 | 64 | 70 | 85 | 108 | |
| Other Income | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Total Income | 29 | 35 | 43 | 51 | 54 | 53 | 59 | 64 | 71 | 86 | 108 | |
| Total Expenditure | 25 | 30 | 36 | 43 | 47 | 47 | 50 | 55 | 61 | 70 | 85 | |
| Operating Profit | 4 | 5 | 6 | 8 | 7 | 6 | 9 | 9 | 10 | 16 | 24 | |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |
| Depreciation | 1 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 3 | 2 | 2 | 5 | 3 | 2 | 5 | 6 | 8 | 15 | 21 | |
| Provision for Tax | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 5 | |
| Profit After Tax | 2 | 1 | 2 | 3 | 2 | 2 | 4 | 5 | 6 | 11 | 16 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 2 | 1 | 2 | 3 | 2 | 2 | 4 | 5 | 6 | 11 | 16 | |
| Adjusted Earnings Per Share | 1.1 | 0.9 | 1 | 2 | 1.3 | 1 | 2.3 | 2.8 | 3.7 | 6.5 | 9.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 27% | 19% | 16% | 15% |
| Operating Profit CAGR | 50% | 39% | 32% | 20% |
| PAT CAGR | 45% | 47% | 52% | 23% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 30% | 25% | 22% | 17% |
| ROCE Average | 39% | 33% | 27% | 20% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 11 | 12 | 14 | 17 | 19 | 21 | 25 | 29 | 35 | 46 | 62 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 6 | 3 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Total Current Liabilities | 14 | 13 | 13 | 18 | 21 | 22 | 25 | 18 | 12 | 15 | 20 |
| Total Liabilities | 25 | 32 | 30 | 37 | 40 | 44 | 50 | 48 | 48 | 62 | 83 |
| Fixed Assets | 5 | 14 | 13 | 13 | 12 | 10 | 8 | 7 | 19 | 21 | 21 |
| Other Non-Current Assets | 5 | 1 | 0 | 0 | 1 | 4 | 13 | 16 | 4 | 11 | 33 |
| Total Current Assets | 15 | 17 | 16 | 23 | 28 | 31 | 29 | 25 | 24 | 31 | 29 |
| Total Assets | 25 | 32 | 30 | 37 | 40 | 44 | 50 | 48 | 48 | 62 | 83 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Cash Flow from Operating Activities | -3 | 7 | 5 | 1 | 2 | 5 | -0 | 9 | 11 | 10 | 22 |
| Cash Flow from Investing Activities | 1 | -11 | -2 | -2 | -1 | -3 | -0 | -4 | -2 | -10 | -23 |
| Cash Flow from Financing Activities | 2 | 4 | -4 | 1 | -0 | -3 | 2 | -6 | -9 | 1 | 2 |
| Net Cash Inflow / Outflow | 0 | 0 | -0 | 0 | 0 | -0 | 1 | -1 | 0 | 1 | 1 |
| Closing Cash & Cash Equivalent | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 2 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.06 | 0.87 | 0.96 | 1.96 | 1.31 | 1.05 | 2.31 | 2.79 | 3.67 | 6.54 | 9.79 |
| CEPS(Rs) | 1.57 | 2.11 | 2.72 | 3.5 | 3 | 2.67 | 3.76 | 3.94 | 4.61 | 7.55 | 10.86 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 6.78 | 7.65 | 8.61 | 10.57 | 11.88 | 12.93 | 15.24 | 17.97 | 21.64 | 28.17 | 37.95 |
| Core EBITDA Margin(%) | 6.71 | 11.48 | 12.92 | 14.34 | 11.84 | 10.56 | 14.37 | 13.32 | 14.11 | 17.84 | 21.35 |
| EBIT Margin(%) | 9.77 | 7.81 | 7.66 | 10.22 | 7.48 | 6.13 | 11.07 | 11.12 | 12.55 | 17.43 | 20.27 |
| Pre Tax Margin(%) | 8.29 | 5.29 | 5.13 | 8.71 | 5.66 | 4.72 | 9.03 | 9.77 | 11.83 | 17.15 | 19.92 |
| PAT Margin (%) | 5.71 | 3.7 | 3.31 | 6.17 | 3.98 | 3.28 | 6.41 | 7.12 | 8.5 | 12.54 | 14.86 |
| Cash Profit Margin (%) | 8.45 | 8.98 | 9.39 | 11.01 | 9.12 | 8.35 | 10.41 | 10.08 | 10.67 | 14.49 | 16.5 |
| ROA(%) | 7.7 | 5.03 | 5.06 | 9.59 | 5.55 | 4.04 | 7.96 | 9.27 | 12.52 | 19.39 | 21.97 |
| ROE(%) | 16.93 | 12.04 | 11.78 | 20.42 | 11.67 | 8.47 | 16.41 | 16.78 | 18.54 | 26.24 | 29.6 |
| ROCE(%) | 17.41 | 13.35 | 14.41 | 19.51 | 12.86 | 9.87 | 18.37 | 18.58 | 24.27 | 35.83 | 38.62 |
| Receivable days | 63.66 | 57.39 | 53.06 | 61.76 | 68.72 | 72.19 | 81.56 | 77.68 | 61.7 | 59.67 | 52.87 |
| Inventory Days | 88.84 | 75.25 | 65.14 | 72.88 | 98.73 | 122.63 | 93.09 | 67.95 | 59.7 | 49.24 | 38.53 |
| Payable days | 91.87 | 73.07 | 56.54 | 54.29 | 62.68 | 93.61 | 92.05 | 74.5 | 70.04 | 65.88 | 69.32 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.43 | 0.48 | 0.34 | 0.32 | 0.32 | 0.29 | 0.29 | 0.19 | 0.06 | 0.19 | 0.17 |
| EV/Core EBITDA(x) | 3.07 | 3.32 | 2.23 | 2.1 | 2.54 | 2.57 | 1.93 | 1.37 | 0.38 | 0.96 | 0.76 |
| Net Sales Growth(%) | 11.46 | 26.51 | 23.23 | 19.42 | 6.14 | -2.59 | 12.71 | 8.44 | 10.35 | 20.72 | 26.37 |
| EBIT Growth(%) | 32.12 | 1.09 | 21.03 | 46.27 | -24.16 | -20.26 | 103.67 | 8.86 | 24.64 | 67.55 | 47 |
| PAT Growth(%) | 40.47 | -17.93 | 10.17 | 104.47 | -33.12 | -19.8 | 120.11 | 20.54 | 31.75 | 78.06 | 49.74 |
| EPS Growth(%) | 40.47 | -17.93 | 10.17 | 104.47 | -33.12 | -19.8 | 120.11 | 20.54 | 31.75 | 78.06 | 49.74 |
| Debt/Equity(x) | 0.73 | 1.05 | 0.75 | 0.72 | 0.69 | 0.53 | 0.56 | 0.28 | 0 | 0.03 | 0.06 |
| Current Ratio(x) | 1.07 | 1.31 | 1.28 | 1.32 | 1.34 | 1.38 | 1.17 | 1.36 | 2.03 | 2.01 | 1.45 |
| Quick Ratio(x) | 0.52 | 0.67 | 0.61 | 0.64 | 0.52 | 0.56 | 0.69 | 0.7 | 1.1 | 1.24 | 0.91 |
| Interest Cover(x) | 6.64 | 3.1 | 3.03 | 6.77 | 4.1 | 4.34 | 5.43 | 8.27 | 17.22 | 63.34 | 58.55 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Sep 2025 | Mar 2026 |
|---|---|---|
| Promoter | 71.54 | 71.54 |
| FII | 0.31 | 0.19 |
| DII | 6.28 | 6.27 |
| Public | 21.88 | 22 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Sep 2025 | Mar 2026 |
|---|---|---|
| Promoter | 1.6 | 1.6 |
| FII | 0.01 | 0 |
| DII | 0.14 | 0.14 |
| Public | 0.49 | 0.49 |
| Others | 0 | 0 |
| Total | 2.24 | 2.24 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
